Rating Change
RBC Capital reiterated its Sector Perform rating on Exelixis, Inc. (NASDAQ:EXEL) on October 08, 2026.
RBC Capital reiterated its Sector Perform rating on Exelixis, Inc. (NASDAQ:EXEL) on October 08, 2026.

At publication ·
Exelixis, Inc. (NASDAQ:EXEL) · reiterate
At a glance
RBC Capital reiterated its Sector Perform rating on Exelixis, Inc. (NASDAQ:EXEL) on October 08, 2026.
Exelixis, Inc. operates in the Healthcare sector. The stock currently trades at $59.02 with a market capitalization of $11.1B. The stock has gained 48.9% over the past 52 weeks.
Analyst coverage from RBC Capital provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Exelixis, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 0 Buy, 10 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 08, 2026 | RBC Capital | Sector Perform | N/A |
| Oct 07, 2026 | Truist Securities | Hold | N/A |
| Aug 19, 2026 | BMO Capital | Market Perform | N/A |
| Aug 06, 2026 | Truist Securities | Hold | N/A |
| Aug 06, 2026 | Stifel | Hold | N/A |
Related Tools: Analyst Ratings Dashboard | View EXEL Stock Page
A rating of Sector Perform from RBC Capital reflects the analyst's outlook on Exelixis, Inc. (NASDAQ:EXEL). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the EXEL forecast page.
Current market data
NASDAQ · EXEL
$59.02
Up: +$0.75 · +1.28%
Live quote updated
Keep reading